Satellite Chemical Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Operating Revenue	39,084	38,736	42,049	40,237	36,766	28,214
Other Revenue	7,332	7,332	3,600	1,250	276.78	343.13
Revenue	46,416	46,068	45,648	41,487	37,043	28,557
Revenue Growth (YoY)	-5.61%	0.92%	10.03%	12.00%	29.72%	165.09%
Cost of Revenue	35,748	35,813	34,922	33,266	30,922	19,515
Gross Profit	10,668	10,255	10,726	8,221	6,121	9,042
Selling, General & Admin	692.78	650.53	885.01	676.09	628.75	569.6
Research & Development	1,704	1,656	1,751	1,626	1,241	1,075
Other Operating Expenses	82.88	12.48	3.12	0.15	120.01	95.15
Operating Expenses	2,503	2,330	2,653	2,304	2,005	1,751
Operating Income	8,164	7,926	8,073	5,917	4,116	7,290
Interest Expense	-966.99	-963.51	-1,082	-1,208	-429.66	-557.07
Interest & Investment Income	84.53	227.3	167.33	224.77	578.83	267.9
Currency Exchange Gain (Loss)	-125.16	-125.16	-86.45	197.02	-130.66	18.32
Other Non Operating Income (Expenses)	87.55	-34.18	-67.74	-24.47	-457.78	-39.72
EBT Excluding Unusual Items	7,244	7,030	7,004	5,105	3,677	6,980
Gain (Loss) on Sale of Investments	-544.27	-1,006	157.12	173.59	-290.56	-31.05
Gain (Loss) on Sale of Assets	10.27	10.29	0	0.47	2.93	0.38
Asset Writedown	-55.55	-56.67	-261.18	-13.55	-4.59	-38.95
Other Unusual Items	100.84	87.84	117.91	102.17	60.07	82.96
Pretax Income	6,756	6,066	7,018	5,368	3,445	6,993
Income Tax Expense	900.83	760.62	956.12	584.27	334.42	980.41
Earnings From Continuing Operations	5,855	5,305	6,062	4,784	3,111	6,013
Net Income to Company	5,855	5,305	6,062	4,784	3,111	6,013
Minority Interest in Earnings	4.46	5.35	9.88	5.74	-14.82	-6.28
Net Income	5,859	5,311	6,072	4,789	3,096	6,007
Net Income to Common	5,859	5,311	6,072	4,789	3,096	6,007
Net Income Growth	-11.46%	-12.54%	26.77%	54.71%	-48.46%	261.62%
Shares Outstanding (Basic)	3,367	3,361	3,373	3,373	3,365	3,356
Shares Outstanding (Diluted)	3,367	3,361	3,373	3,373	3,365	3,374
Shares Change (YoY)	0.35%	-0.35%	0.01%	0.24%	-0.28%	12.00%
EPS (Basic)	1.74	1.58	1.80	1.42	0.92	1.79
EPS (Diluted)	1.74	1.58	1.80	1.42	0.92	1.78
EPS Growth	-11.77%	-12.23%	26.76%	54.35%	-48.32%	222.87%
Free Cash Flow	7,703	6,947	7,450	5,590	1,971	-394.89
Free Cash Flow Per Share	2.29	2.07	2.21	1.66	0.59	-0.12
Dividend Per Share	0.500	0.500	0.500	0.400	0.400	0.178
Dividend Growth	-	-	25.00%	-	124.34%	187.58%
Gross Margin	22.98%	22.26%	23.50%	19.82%	16.52%	31.66%
Operating Margin	17.59%	17.21%	17.69%	14.26%	11.11%	25.53%
Profit Margin	12.62%	11.53%	13.30%	11.54%	8.36%	21.03%
Free Cash Flow Margin	16.60%	15.08%	16.32%	13.47%	5.32%	-1.38%
EBITDA	13,000	12,692	12,559	8,199	5,615	8,353
EBITDA Margin	28.01%	27.55%	27.51%	19.76%	15.16%	29.25%
D&A For EBITDA	4,836	4,766	4,486	2,282	1,499	1,063
EBIT	8,164	7,926	8,073	5,917	4,116	7,290
EBIT Margin	17.59%	17.21%	17.69%	14.26%	11.11%	25.53%
Effective Tax Rate	13.33%	12.54%	13.62%	10.88%	9.71%	14.02%
Revenue as Reported	46,416	46,068	45,648	41,487	37,043	28,557

Updated Mar 31, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.